Literature DB >> 16352463

Laboratory animal models for human Taenia solium.

Guillermina Avila1, Nancy Teran, Laura Aguilar-Vega, Pablo Maravilla, Pilar Mata-Miranda, Ana Flisser.   

Abstract

Human beings are the only hosts of adult Taenia solium; thus, many aspects of the host-parasite relationship are unknown. The development of successful experimental models of taeniasis allows in-depth investigations of the host-parasite relationship. We established experimental models in hamsters, gerbils and chinchillas. Here we review our findings regarding the characteristics of the tapeworms, their anchoring site and development, as well as the humoral and cellular immune response they elicit. We also used statistics to analyze the data obtained in different infections performed along several years. Furthermore, we compared the size of T. solium rostellum and strobila recovered from hamsters and gerbils to those obtained from humans. Our data indicate that these rodents are adequate experimental models for studying T. solium in its adult stage; that parasites induce immune responses and that hamsters seem to be more permissive hosts than gerbils, since parasites survive for longer times, grow longer and develop more, and the inflammatory response in the intestinal mucosa against T. solium is moderate. Finally, chinchillas are the most successful experimental definitive model for adult T. solium, since tapeworms with gravid proglottids are obtained, and the life cycle can be continued to the intermediate host.

Entities:  

Mesh:

Year:  2005        PMID: 16352463     DOI: 10.1016/j.parint.2005.11.015

Source DB:  PubMed          Journal:  Parasitol Int        ISSN: 1383-5769            Impact factor:   2.230


  1 in total

1.  Development of Taenia pisiformis in golden hamster (Mesocricetus auratus).

Authors:  Elizabeth Toral-Bastida; Adriana Garza-Rodriguez; Diego E Jimenez-Gonzalez; Ramon Garcia-Cortes; Guillermina Avila-Ramirez; Pablo Maravilla; Ana Flisser
Journal:  Parasit Vectors       Date:  2011-07-25       Impact factor: 3.876

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.